Shuji Takei

1.7k total citations · 1 hit paper
19 papers, 922 citations indexed

About

Shuji Takei is a scholar working on Hematology, Rheumatology and Immunology. According to data from OpenAlex, Shuji Takei has authored 19 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Rheumatology and 6 papers in Immunology. Recurrent topics in Shuji Takei's work include Autoimmune and Inflammatory Disorders Research (13 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Shuji Takei is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (13 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Shuji Takei collaborates with scholars based in Japan, Australia and United States. Shuji Takei's co-authors include Norihiro Nishimoto, Masaaki Mori, Naomi Iwata, Shumpei Yokota, Hiroaki Umebayashi, Minako Tomiita, Yukoh Aihara, Tadamitsu Kishimoto, Tomoyuki Imagawa and Mari Miyoshi and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

Shuji Takei

18 papers receiving 885 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

2008 579 citations Shumpei Yokota, Tomoyuki Imagawa et al. The Lancet profile →

Peers

Countries citing papers authored by Shuji Takei

Since Specialization

Citations

This map shows the geographic impact of Shuji Takei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Takei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Takei more than expected).

Fields of papers citing papers by Shuji Takei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Takei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Takei. The network helps show where Shuji Takei may publish in the future.

Co-authorship network of co-authors of Shuji Takei

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Takei. A scholar is included among the top collaborators of Shuji Takei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Takei. Shuji Takei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Structural analysis reveals how tetrameric tyrosine-phosphorylated STAT1 is targeted by the rabies virus P-protein 2025 ·Science Signaling ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xiaomei Sun, Shuji Takei, (unknown), (unknown), Xinxin Jiang, Shunsuke Kita, Katsumi Maenaka, Mika Hirose, Min Yao, Paul R. Gooley, Gregory W. Moseley, Yukihiko Sugita, Toyoyuki Ose	0
2	AB0495 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data 2018 ·Annals of the Rheumatic Diseases ·Naoto Tamura, Masataka Kuwana, Tatsuya Atsumi, Shuji Takei, Masayoshi Harigai, Takao Fujii, Hiroaki Matsuno, Tsuneyo Mimori, Shigeki Momohara, Kazuhiko Yamamoto, (unknown), Yutaka Endo, Naonobu Sugiyama, Tomohiro Hirose, Yosuke Morishima, (unknown), Michiaki Takagi	10
3	Evidence-based clinical practice guideline for adult Still’s disease 2018 ·Modern Rheumatology ·Toshihide Mimura, Yuya Kondo, Akihide Ohta, Masahiro Iwamoto, (unknown), Nami Okamoto, Yasushi Kawaguchi, Hajime Kono, Yoshinari Takasaki, Shuji Takei, Norihiro Nishimoto, Manabu Fujimoto, Yu Asanuma, Akio Mimori, Naoko Okiyama, Shunta Kaneko, Hiroyuki Takahashi, Masahiro Yokosawa, Takayuki Sumida	45
4	Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still’s disease: A multicenter retrospective study 2017 ·Modern Rheumatology ·Yohei Kirino, Yasushi Kawaguchi, Yoshifumi Tada, Hiroshi Tsukamoto, Toshiyuki Ota, Masahiro Iwamoto, Hiroki Takahashi, Kohei Nagasawa, Shuji Takei, Takahiko Horiuchi, Hisae Ichida, Seiji Minota, Atsuhisa Ueda, Akihide Ohta, Yoshiaki Ishigatsubo	24
5	Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey 2016 ·Arthritis & Rheumatology ·Naoyasu Ueda, Hiroaki Ida, Masakazu Washio, Hisaaki Miyahara, Shoji Tokunaga, Fumiko Tanaka, Hiroki Takahashi, Koichi Kusuhara, Koichiro Ohmura, Manabu Nakayama, Osamu Ohara, Ryuta Nishikomori, Seiji Minota, Shuji Takei, Takao Fujii, Yoshiaki Ishigatsubo, Hiroshi Tsukamoto, Tomoko Tahira, Takahiko Horiuchi	14
6	Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases 2014 ·Modern Rheumatology ·Ichiro Kobayashi, Masaaki Mori, Kenichi Yamaguchi, Shuichi Ito, Naomi Iwata, Kenji Masunaga, Naoki Shimojo, Tadashi Ariga, Kenji Okada, Shuji Takei	12
7	AB0435 Effects of Prior Use of BIOLOGICS on the Safety and Effectiveness of Abatacept Administered with or without Methotrexate in Japanese Patients with Rheumatoid Arthritis: Sub-Analysis of the Abatacept All-Cases Post-Marketing Surveillance 2014 ·Annals of the Rheumatic Diseases ·Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Tsuneyo Mimori, Juhee Ryu, Yoshinari Takasaki, Shuji Takei, Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Michiaki Watanabe, Takayoshi Koike	1
8	Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients 2012 ·Modern Rheumatology ·Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka	68
9	THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7,901 patients in japan 2012 ·Annals of the Rheumatic Diseases ·Hisashi Yamanaka, Masayoshi Harigai, Shigeko Inokuma, Naoki Ishiguro, Juhee Ryu, Shuji Takei, Tsutomu Takeuchi, Yoshiya Tanaka, Yuji Sano, Takayoshi Koike	3
10	Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan 2012 ·Modern Rheumatology ·Rie Suematsu, Akihide Ohta, Emi Matsuura, Hiroki Takahashi, Takao Fujii, Takahiko Horiuchi, Seiji Minota, Yoshiaki Ishigatsubo, Toshiyuki Ota, Shuji Takei, (unknown), Hisako Inoue, Syuichi Koarada, Yoshifumi Tada, Kohei Nagasawa	44
11	Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients 2011 ·Modern Rheumatology ·Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka	37
12	Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan 2011 ·Modern Rheumatology ·Rie Suematsu, Akihide Ohta, Emi Matsuura, Hiroki Takahashi, Takao Fujii, Takahiko Horiuchi, Seiji Minota, Yoshiaki Ishigatsubo, Toshiyuki Ota, Shuji Takei, (unknown), Hisako Inoue, Syuichi Koarada, Yoshifumi Tada, Kohei Nagasawa	52
13	[Effective cyclophosphamide pulse therapy for an young infant with severe dermatomyositis]. 2011 ·PubMed ·Ayako Senju, Masayuki Shimono, (unknown), Masahiro Ishii, K. Takano, (unknown), Shuji Takei, Yasuhito Nerome	3
14	Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial breakdown → 2008 ·The Lancet ·Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Yukoh Aihara, Shuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi, Minako Tomiita, Norihiro Nishimoto, Tadamitsu Kishimoto	579
15	Efficacy and safety of tocilizumab in 48-week treatment in children with systemic juvenile idiopathic arthritis 2007 ·Annals of the Rheumatic Diseases ·(unknown), Tomoyuki Imagawa, Masahiko Mori, (unknown), Takako Miyamae, Sadayoshi Ito, Yasuo Aihara, Yasuhito Nerome, Hiroyuki Imanaka, Shuji Takei, (unknown), Naomi Iwata, Minako Tomiita, Mari Miyoshi, Takuji Murata, Hiroaki Umebayashi, Naoki Nishimoto, T Kishimoto	1
16	[Multi-center analysis of calcinosis in children with juvenile dermatomyositis]. 2003 ·PubMed ·Takako Miyamae, Masaaki Mori, Yasuji Inamo, Y Kohno, Shuji Takei, (unknown), Takuji Murata, (unknown), Hiroshi Kawai, Yukiko Hirano, (unknown), (unknown), Shumpei Yokota	8
17	Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis 2000 ·Journal of the American Academy of Dermatology ·Shinichi Yotsumoto, Yoshihiro Takahashi, Shuji Takei, (unknown), Koichiro Miyata, Tamotsu Kanzaki	12
18	Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis 2000 ·Journal of the American Academy of Dermatology ·Shinichi Yotsumoto, Yoshihiro Takahashi, Shuji Takei, (unknown), Koichiro Miyata, Tamotsu Kanzaki	5
19	[Two cases with SLE and MCTD developed after a long period of chronic arthritis that was initially diagnosed as JRA]. 1997 ·PubMed ·Shuji Takei, Nobuaki Maeno, (unknown), (unknown), Haruyo Mori, (unknown), Hiroyuki Imanaka, (unknown), Kohei Miyata	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact